Abstract. Type II collagen is a major component of cartilage providing structural integrity to the tissue. Type II procollagen can be expressed in two forms by differential splicing of the primary gene transcript. The two mRNAs either include (type IIA) or exclude (type IIB) an exon (exon 2) encoding the major portion of the amino (NH2)-propeptide (Ryan, M. C., and L. J. Sandell . 1990. J. Biol. Chem. 265 :10334-10339) . The expression of the two procollagens was examined in order to establish a potential functional significance for the two type II procollagen mRNAs . First, to establish whether the two mRNAs are functional, we showed that both mRNAs can be translated and the proteins secreted into the extracellular environment . Both proteins were identified as type II procollagens . Secondly, to test the hypothesis that differential expression of type II procollagens may be a marker for a distinct population of cells, specific procollagen mRNAs were localized in tissue by in situ hybridization to oligonucleotides spanning the exon junctions . Embryonic vertebral column was chosen as a source of tissue undergoing rapid chondrogenesis, allowing the examination of a variety of cell types related to cartilage . In this issue, each procollagen mRNA had a distinct tissue distribution during chondrogenesis with type IIB expressed in chondrocytes and type IIA ex-YPE II collagen is the predominant collagenous component of cartilage composing >50 % of the extracellular matrix . Like type I collagen, the most abundant col lagen in vertebral organisms, it is an interstitial collagen' synthesized as a procollagen monomer, assembled into molecular trimers and processed extracellularly to remove NH2-and COON-terminal extension propeptides . The interstitial collagen monomer contains a non-interrupted Gly-XY protein domain of -1,014 amino acids, flanked by the globular propeptides . The COOH-terminal propeptide of ti 275 amino acids is connected to the main triple helix by a short telopeptide, is highly conserved between interstitial collagens, and is thought to be involved in initiation of trimer formation .
pressed in cells surrounding cartilage in prechondrocytes. The morphology of the cells expressing the two collagen types was distinct : the cells expressing type IIA are narrow, elongated, and "fibroblastic" in appearance while the cells expressing type IIB are large and round . The expression of type IIB appears to be correlated with abundant synthesis and accumulation of cartilagenous extracellular matrix . The expression of type IIB is spatially correlated with the high level expression of the cartilage proteoglycan, aggrecan, establishing type IIB procollagen and aggrecan as markers for the chondrocyte phenotype . Transcripts of type II collagen, primarily type IIA, are also expressed in embryonic spinal ganglion. While small amounts of type II collagen have been previously detected in noncartilagenous tissues, the detection of this new form of the collagen in relatively high abundance in embryonic nerve tissue is unique. Taken together, these findings imply a potential functional difference between type IIA and type IIB procollagens and indicate that the removal of exon 2 from the pre-mRNA, and consequently the NH2-propeptide from the collagen molecule, may be an important step in chondrogenesis . In addition, type II procollagen, specifically type IIA, may function in noncartilage tissues, particularly during development .
collagen monomer contains a non-interrupted Gly-XY protein domain of -1,014 amino acids, flanked by the globular propeptides . The COOH-terminal propeptide of ti 275 amino acids is connected to the main triple helix by a short telopeptide, is highly conserved between interstitial collagens, and is thought to be involved in initiation of trimer formation . The NH2-terminal propeptide shows more structural and sequence diversity among the interstitial collagens, but generally consists of a short globular domain followed by a cysteine-rich domain, a Gly-XY domain of40-60 residues, and a short connecting telopeptide (Sandell and Boyd, 1990) . It has been suggested that the propeptides, particularly the NH2-propeptide, are involved in feedback regulation of collagen synthesis and in the formation of fibrils in the extracellular matrix (Wiestner et al ., 1979; Wu et al., 1986; Fleischmajer et al., 1983) .
Traditionally, the presence of type II collagen has served as a marker for cartilage, however, small amounts of type II collagen have been detected at the epitheliomesenchymal interfaces during morphogenesis of the cartilaginous neurocranium and in other noncartilaginous tissues of developing chicken embryos (Linsenmayer et al ., 1977; von der Mark et al ., 1977; Newsome et al., 1976; Smith et al., 1976; Linsenmayer and Little, 1978 ; Kosher and Solursh, 1989) . In prechondrogenic limb mesenchymal cells, type II collagen mRNA has been detected prior to the onset of overt cartilage differentiation and before accumulation of detectable amounts of type II collagen (Kravis and Upholt, 1985; Kosher et al ., 1986) . Kosher et al. (1986) suggested that low level expression of type II collagen gene by chondrogenic progenitor cells may represent a molecular manifestation of the state of determination of the cells, however, the role of type II collagen in prechondrocytic and nonchondrocytic cells is not known.
Recently, two type II procollagen transcripts were found to be produced from the single COL2A1 gene . We reported the finding of an exon (exon 2) present in the human COL2A1 gene ) that was not present in type II collagen cDNA clones from human chondrocytes (Baldwin et al., 1989) or rat chondrosarcoma (Kohno et al., 1984) . This exon encodes the collagenase resistant, cysteine-rich domain of the NH2-propeptide . The protein domain contains 69 amino acids, including 10 cysteine residues, is conserved between interstitial collagens chains al(I), al(II), al(III), a2(V), and is homologous to a domain present in the extracellular matrix proteins thrombospondin and von Willebrand factor . Further investigation of type II procollagen mRNA transcripts revealed that this domain is expressed in embryonic and adult chondrocyte mRNA populations and is subject to alternative splicing in the pre-mRNA . Northern blot analysis using oligonucleotide probes spanning the boundaries between exon 1 and exon 2 (type IIA) or exon 1 and exon 3 (type IIB) indicated that type IIB mRNA was the predominant form expressed in RNA isolated from cartilage cells although both mRNAs were present in the RNA populations examined . We suggested that the expression of exon 2 may be a marker for a distinct population of cells and have designed this study to test that hypothesis .
The expression of the two procollagens was examined in medium from cultured juvenile costal chondrocytes (shown previously to express both type II procollagen mRNAs) . These cells translated and secreted both type II procollagens at relatively high levels . Identification ofthe cells synthesizing the two type II procollagens was accomplished by in situ hybridization to mRNA using oligonucleotide probes designed to identify specific mRNAs.
Materials and Methods

Cell Cultures
Procollagens were isolated from medium of human costal chondrocytes. Costal cartilage was obtained from ribs removed during pectus excavatum
The Journal of Cell Biology, Volume 114, 1991 repair. Chondrocytes were isolated by dispersion with proteases as follows . Cartilage slices were incubated at 37°C with hyaluronidase (1 mg/ml in PBS; bovine testicular from Sigma Chemical Co ., St. Louis, MO, for 10 min, followed by 0.25 % trypsin (GIBCO/BRL, Gaithersburg, MD) for 45 min) . The cartilage was then chopped in small fragments and incubated at 37°C with collagenase (3 mg/ml in serum-free culture medium, clostridial peptidase from Worthington Biochemical Corp., Freehold, NJ) for 24 h for articular cartilage or 48 h for costal cartilage. The dispersed cells were then washed with Ca"-and Mgr -free PBS and cultured in Dulbecco's modified Eagle's medium supplemented with 10% FCS with medium changes every 3-4 d, as described previously (Goldring et al ., 1986 ) . Costal chondrocytes from two different individuals (C-29: 16-yr-old female, 16 d of culture; C-30: 6-yr-old female, 8 d of culture) were used for the experiments described in this study. The cells were labeled 24 h after the last medium change for a further 24 h in serum-free Dulbecco's modified Eagle's medium (5 ml per 10-cm dish) supplemented with 50 kg/ml ascorbate and 50 pg/ml ß-aminoproprionitrile fumarate and containing 25 pCi/ ml of [3 H]proline (>20 Ci/mmol; Amersham Corp., Arlington Heights, IL) and 50 pCi/ml of [35 S]cysteine (1071 Ci/mmol ; Amersham Corp .) .
Isolation of Procollagens
The culture medium containing [3H]proline labeled proteins was adjusted to 5 mM EDTA, and 1 mM N-ethylmaleirnide . Proteins were precipitated by the addition of 300 mg/ml of ammonium sulfate which was stirred overnight at 4°C. The precipitate was collected by centrifugation at 15,000 rpm, 4°C, for 30 min in an SS 34 rotor (Sorvall Instruments, Newton, CT) using an RC 5C centrifuge (Sorvall Instruments) . The precipitate was suspended in 0.05 M Tris-HCI, pH 7.5, 0.25 M NaCl, 0.1 % Triton X-100. The samples were treated with 0.25 % diisopropyl fluorophosphate for 4 h on ice and then dialyzed against the same buffer. Samples were run over a Sepharose-gelatin column (Pharmacia Fine Chemicals, Piscataway, NJ) to remove fibronectin. When indicated, aliquots were digested with purified bacterial collagenase (Morris et al ., 1983) or pepsin. Labeled proteins were visualized by fluorography after separation on SDS-PAGE (Burgeson et al ., 1976) using Amplify (Amersham Corp.) . Cyanogen bromide peptide mapping of gel bands was performed according to the method of Sokolov et al, . (1989) using the 16-h incubation . Human type I procollagen was prepared from the medium of primary skin fibroblasts incubated with [ 3H]proline (Amersham Corp.) for 24 h . The medium was precipitated with ammonium sulfate and treated with diisopropyl fluorophosphate as described above. The sample was then fractionated under nondenaturing conditions on a Sepharose-6B column (Pharmacia Fine Chemicals) and the fractions containing type I procollagen pooled and frozen .
[3H]Proline-labeled mixture of chick types II and XI collagen was obtained from organ culture of chick sterna as previously described (Morris and Bachinger, 1987) . Labeling was for 60 min and purification proceeded only to passage over DEAF cellulose to remove proteoglycan. Unless otherwise indicated, all reagents were purchased from Sigma Chemical Co .
In Situ Hybridization
Tissue used in this study was human fetal vertebral column, 57-d gestation, (Carnegie Stage 23), provided by the Central Laboratory for Human Embryology at the University of Washington . The age was determined from crown to rump length by the method of Shepard (1975) . Tissue was frozen in O .C.T. compound (Miles Laboratories Inc., Elkhart, IL) and sectioned with a cryostat, or fixed in 4% paraformaldehyde, embedded in Epon, and sectioned on a microtome . For in situ hybridization, frozen sections were used with in situ hybridization procedures described by Lewis et al ., (1985) . In brief, slides with a single section of vertebral tissue (6-10 lim) were warmed to room temperature. Sections are postfixed in 4% paraformaldehyde, treated with acetic anhydride (0.25% in 0.1 M triethanolamine), dehydrated, delipidated, and air dried . An 35S-labeled oligonucleotide probe was added to hybridization buffer containing 50% deionized formamide, 10% dextran sulfate, 300 mM NaCl, 10 mM Tris, 1 mM EDTA, Ix Denhardt's (0.02 % each ofBSA, Ficoll, and polyvinylpyrollidone), 0.5 mg yeast tRNA/ml, and 10 mM dithiothreitol . A 45-Pl aliquot (containing 2 .5 pmol of probe/ml) was applied to the slide . Specific activity estimates ranged from 1 .0 to 1 .2 x 10 7 cpm/pmol . Sections were coverslipped and slides were incubated overnight in moist chambers at 37°C . After the overnight incubation, coverslips were removed and sections washed four times in lx standard saline citrate (lx SSC = 150 mM NaCl, 15 mM sodium citrate) for 15 min at 50°C. In some cases, stringency was increased by elevating wash temperatures . Slides were washed twice for 1 h at room temperature. The sections were dehydrated through a graded series of alcohols containing 300 mM ammonium acetate and exposed to Hyperfilm BMax (Amersham Corp .) for 3 d. Slides were dipped in NTB 2 emulsion (Eastman Kodak Co ., Rochester, NY), diluted 1 :1 with 600 mM ammonium acetate and exposed for 8-12 d . The emulsion was developed in D-19 (Eastman Kodak Co.), diluted 1 :1 with distilled water at 16°C. Sections were counterstained with cresylviolet acetate and coverslipped . Autoradiographs were analyzed with the aid of a MCID Image Analysis System (Imaging Research, St . Catharines, Ontario, Canada) .
Oligonucleotide Probes
Probes specific for type IIA and type IIB collagen have been described and contain the following . For type IIA, 12 nucleotides of exon 1 and 12 nucleotides of exon 2, 5'-TGCCAGCCTCCT GGACATCCTGGC-3 ; for type IIB, 12 nucleotides of exon 1 and 12 nucleotides of exon 3, 5'-CTCCTGGTTGCCGGACATCCTGGC-3 . Other oligonucleotides used in this report were the following . All type II collagen mRNAs, a 21mer oligonucleotide of exon 8, 5'-GCCTTCTGATCAAAT CCTCCA-3 ; aggrecan (nucleotides 1,096-1,120) of cDNA reported by Baldwin et al . (1989) , 5'-CTCGTGCCAGATCATCACCACACAT 3 ; al(I) procollagen, exon 1/exon 2 junction, 5'-TGATTGGTGGGATGTCTTCGT CTT3 ' (d'Alessio et al ., 1988) . Oligonucleotides were synthesized with a DNA synthesizer (Applied Biosystems, Inc ., Foster City, CA) and purified by passage through a 5 % acrylamide gel ; only the full-sized oligomers were eluted . Oligonucleotides were labeled with 5'-[a-thiol-3551-ATP (New England Nuclear, Boston, MA) using terminal deoxynucleotidyl transferase (Bio-Rad Laboratories, Gaithersburg, MD) .
Results
Translation and Secretion of Two Procollagens
Since mRNAs generated by alternative splicing of a gene are not necessarily translated into functional proteins, it was necessary to determine whether the two type II collagen mRNAs could produce protein products. A diagram of the COL2A1 gene, type IIA and type IIB procollagen mRNAs, and the predicted procollagens is presented in Fig. 1 . To determine whether two procollagens could be translated from the two mRNAs, media from cultures of freshly isolated juvenile costal chondrocytes were analyzed . These cells were chosen for analysis because we had previously demonstrated that they express both type IIA and type IIB collagen mRNAs ) and do not contain detectable levels of type I collagen mRNA. Upon incubation of these cells with [3H]proline, collagens and fibronectin were the most prominent radiolabeled components due to the relatively high content of proline in these matrix proteins.
Characterization of the two procollagen molecules and processing intermediates secreted by these chondrocytes demonstrated that they have the classical characteristics of specific procollagens including sensitivity to degradation by bacterial collagenase, pepsin sensitivity of the propeptide domains, predicted migration patterns on SDS-PAGE with and without reduction, and a cyanogen bromide peptide pattern characteristic oftype II collagen . Fig. 2 A shows the pattern ofcollagen chains separated by SDS-PAGE under reducing conditions . Previous analysis of sequence implied from cDNA and genomic clones have shown that the NH2-propeptide of type IIA Su et al ., 1989) , the C-propeptide (Sandell et al., 1984) and triple helix (Sandell, et al., 1983 ; Upholt and Sandell, 1986 ) of type II collagen are similar to those ofthe al chain oftype I collagen in amino acid content and peptide length with one exception: the NH2-propeptide of type II procollagen contains a longer Gly-XY domain (30 amino acids) than type I procollagen. In analogy to al(I) collagen, four forms of the type IIA chain were expected : pNC procollagen containing both Sandell et NHZ-and COOH-propeptides, pC collagen containing only the COOH-propeptide, pN collagen containing only the NHZ-propeptide, and the fully processed al(II) chain. With the presence of two type II procollagens, an additional pNC (without exon 2) and pN (without exon 2) procollagen is predicted . Samples from two separate costal chondrocyte cultures were analyzed . Passage through a gelatin-Sepharose column removed fibronectin . Here, five collagenase-sensitive bands were observed, one alpha chain and four bands of procollagens . Under these reduced conditions, we predict that the pN (+ exon 2) procollagen cannot be resolved from the pC procollagen . Subsequent analyses of the juvenile costal chondrocytes were performed on sample C-30. To determine which of the collagenase-sensitive bands 1-5 were procollagens, the sample was digested with pepsin under conditions whereby only the globular domains of the procollagens would be removed . Fig. 2 B shows the predicted pepsin resistance of the mature collagen alpha chain and the pepsin sensitivity of the four more slowly migrating bands : all predicted procollagens (lane 2) were reduced to the size of alpha chains (lane 3). To exclude the possibility that any of these bands could be derived from type III procollagen, an interstitial collagen that contains interchain pepsin-resistant disulfide bonds, the digested sample was electrophoresed without prior reduction of disulfide bonds ( Fig. 2 B, lane 4) . The lack of trimeric molecules (>300,000 D) after pepsin digestion and electrophoresis under nonreducing conditions indicated that there was no type III procollagen in the sample.
The analysis presented in Fig . 2 To more clearly analyze the pNa chains, sample C30 was electrophoresed on a 5 % gel without reduction of disulfide bonds. Because they contain interchain disulfide bonds, procollagen and pC collagen (and type IX where present) migrate near the top of the gel. Lane 1, sample C30; arrows indicate two possible forms of pNa and below these is the a chain. Lane 2, human type I procollagen ; arrow indicates the pNa(I) chain and below this are the al, pNa2, and the a2 chains. Lane 3, chick type II procollagen ; arrow in lane 1 indicates the pNa chain which lacks the cysteine-rich domain and below this is the a chain. The chick sternal cartilage sample contains type XI, identified as previously described (Thom and Morris, 1991) . (D) CNBr peptide mapping of type II procollagen chains. Sample C30 was resolved by SDS-PAGE on a 5 % gel which is shown horizontally at the top. Electrophoretic migration was from right to left . Band 1 is the a chain, band 2 is pNIIB, band 3 is pCa and pNIIA, band 4 is pNCIIB and band 5, the slowest migrating, is thepresumptive pNCIIA . After fluorography, each of the five bands was excised from the gel, digested with CNBr (see Materials and Methods), and analyzed by SDS-PAGE on a 10% gel. The CNBr digestion pattern of pepsin extracted human type II collagen is shown flanking the radiolabeled samples. These samples were electrophoresed on an identical SDS-PAGE and stained with Coomassie blue . procollagens, advantage was taken of the fact that the COOH-propeptide contains interchain disulfide bonds and therefore procollagens containing this region, the pNC and pC (>375,000 D), form covalent trimers. These large trimers, without disulfide bond reduction, would migrate near the top of the 5 % SDS-PAGE gel . Under nonreducing conditions, the pN procollagens still migrate in the middle of the lane and are consequently more readily resolved . The costal chondrocyte sample is compared to human type I procollagen and chick sternal type II . Unlike the SDS-PAGE gels shown in Fig . 2, A and B, multiple high molecular mass bands can be observed near the top of the gel . The pN procollagens are indicated by arrows and the mature alpha chain migrates ahead of the procollagens. In the type I collagen sample, the two predicted bands, cel(I) and pNa(I) procollagen are observed . In the chicken sternal chondrocyte sample, two chains are also predicted and observed . Note that the pNal(I) chain (lane 2) migrates more slowly than the chick sternal pNal(II) (lane 3) presumably because the pNal(I) chain contains cysteine-rich domain while the chicken pNal(II) chain does not . Chicken sternal chondrocytes express type IIB procollagen because, as we have shown previously and will show subsequently in this publiSandell et al . Alternatively Spliced Procollagens cation, the predominant form of type II collagen in cartilage mRNA is type IIB. In the costal chondrocyte sample, two procollagen bands were observed which migrated at sizes consistent with those of type HA and type IIB pN procollagens.
To confirm that these procollagens were all forms of the type II collagen, cyanogen bromide peptide analysis of each gel band was performed (Fig . 2 D) . Each band (labeled 1-5 as in Fig . 2 A) yielded identical peptide maps characteristic of type II collagen . The same pattern of peptides is observed in both type HA and type IIB procollagens due to a cleavage at the methionine at amino acid three of the Gly-XY domain . The NHz-propeptides cannot be detected . The five bands can be now identified as : band 1, pNC of type HA ; band 2, pNC of type IIB ; band 4, pN of type IIB ; band 5, the mature a chain . Band 3 (Fig . 2 D, and lane 3) is presumably a mixture of pC and pN (+ exon 2) and shows only one cyanogen bromide peptide pattern .
Chondrocytes Synthesize Type IM Procollagen
Previous results using Northern blot analysis of RNA indicated that type IIB procollagen was the major collagen ex- pressed in cultured bovine articular chondrocytes, cultured human costal chondrocytes, and vertebral chondrocytes ) and fetal bovine auricular and cultured fetal vertebral chondrocytes (Sandell, L . J. unpublished observations) . Using oligonucleotide probes spanning the junction of exon 1 and exon 2 (type IIA) or exon 1 and exon 3 (type 11B), the expression of type II collagens was investigated by in situ hybridization to mRNA . These exonspanning probes are the same probes previously used in Northern blot analysis : they are described in Materials and Methods and indicated in the diagram in Fig . 1 . The results shown in Fig . 3 demonstrate the abundant expression of type IIB procollagen in fetal bovine articular cartilage (Fig . 3, a The Journal of Cell Biology, Volume 114, 1991 and b) and fetal human digit cartilage (Fig . 3, c and d) . These tissues have morphological characteristics of cartilage, with rounded lacunae, abundant hyaline extracellular matrix and staining of the matrix with cresyl violet . Note that the cells show strong hybridization with the oligonucleotide probe, while the extracellular matrix shows only background hybridization . These tissues showed no hybridization with probes for type IIA procollagen or type I procollagen .
Localization of Type II Procollagen Expression in Specific Pbpulations of Cells of the Developing Vertebral Column
The presence of both type IIA and type IIB collagen mRNAs has been demonstrated in populations of total RNA isolated from fetal skeletal tissue and cultured costal chondrocytes . In preparations of isolated RNA, Northern blots probed with exon-spanning oligonucleotides indicated that there was relatively more type IIB collagen mRNA in fetal skeleton than type IIA collagen mRNA . Since the fetal skeleton is undergoing chondrogenesis and contains cells at various stages in the developmental process, the cellular localization of type IIA and type IIB collagen mRNAs was examined by in situ hybridization . The same exonspanning oligonucleotide probes described previously were used . At this time of development (57 d), the vertebra were in a late stage of chondrification and the cells in the center of the more developed cranial vertebra were likely hypertrophic . Type I collagen mRNA, characteristic of mesenchymal cells was present in the intervertebral area (Fig. 4 a) . Localization of type II mRNAs revealed that type IIA was localized in cells surrounding the cartilage (Fig. 4 b) in the prechondrogenic area that will eventually become the articular endplate of the vertebral body while type IIB was present primarily in cartilagenous tissue of the centrum (the precursor of the vertebral body) where extracellular matrix was accumulated around the cells (Fig . 4 c) . Although most of the tissue has been lost in the freezing procedure, some type IIA can also be seen in the perichondrium remaining on the dorsal side of the vertebral body. The expression of collagens was not radially symmetrical across the tissue (seen in the cross sections) and appears to be more abundant on the ventral side of the vertebral body (sagittal section) at this plane of sectioning . Fig. 4 d shows the tissue hybridized with a probe for exon 8 of the COL2A1 gene . This exon is present in both type IIA and type IIB procollagens and hybridizes with all type II procollagen-synthesizing tissues as expected .
While the distribution of these collagen mRNAs was observed in the film autoradiographs, more resolution was obtained with emulsion autoradiography (Fig. 5) . Cells in the vertebral bodies (Fig. 5 a, VB) are rounded and the tissue is cartilagenous in morphology, while the cells surrounding the vertebral body and in the intervertebral area (IVA) have an elongated, fibroblastic character. Type I procollagen mRNA was synthesized by a distinct population of cells in the intervertebral area while type IIB procollagen mRNA was synthesized in cells of the vertebral body. Between the intervertebral area and the cartilagenous zone, a population of cells synthesized type IIA procollagen mRNA . Some hybridization to type IIA is also apparent in the IVA. From this data, it is not possible to determine whether a transitional population of cells synthesizes both type IIA and type IIB procollagen.
The cellular expression of types I, IIA, and IIB collagen mRNAs is shown in Fig . 6 . This area is the junction between the cartilagenous tissue of the centrum/vertebral body and the intervertebral area . The progression from cells synthesizing type I to those synthesizing type IIA collagen to those synthesizing type IIB collagen can be seen . The particular morphology of the cells can also be observed . There appears to be an abrupt change in gene expression between the type I procollagen-synthesizing cells of the intervertebral area and the cells beginning to express type II procollagen . The cells expressing type IIA collagen accumulate very little extracellular matrix while the cells synthesizing type IIB collagen are surrounded by stainable cartilagenous matrix . From Fig . 6 In light of the differential expression of type IIA and type IIB procollagen mRNAs, we determined whether mRNA for the other predominant cartilage extracellular matrix protein, the chondroitin sulfate proteoglycan, was expressed in a distinct pattern . Fig. 7 shows vertebral tissue hybridized with an oligonucleotide encoding a region of the core protein of the large cartilage aggregating proteoglycan, recently named aggrecan (Doege et al., 1990 ) .
Expression of Type IIA Procollagen in Nonchondrocytic Cells
During the analysis of type II procollagen expression in the developing vertebral column, distinct expression of type II collagen mRNA was observed in the cells forming the facet joint and in the spinal ganglion . Fig . 8 , a-c are cross sections of the vertebral column in a plane through the spinal ganglion . The spinal ganglion shows positive hybridization to the type IIA procollagen mRNA probe. Sagittal sections on a plane through the spinal ganglion and facet joint are also shown (Fig . 8, d and e) . The beginning of facet joint formation between the vertebral processes can be seen at the right Figure 7 Autoradiograph of the localizat body and other cartilagenous structures at the in this photograph . In Fig . 8 e, i ticularly high concentration of type HA procollagen at the interface between the vertebral processes in the developing facet joint . Type 1113 is not detected in these cells, but is abundant in the adjacent cartilage . Again, the cells synthesizing type IIA had morphological features characteristic of fibroblasts .
Discussion
Alternative splicing of pre-mRNA is now known to be widespread importance for the generation of protein forms . By this mechanism functions ranging " intracellular and extracellular localization to enzyme activity can be modulated by expression of the appropriate "in do- is the predominant type 11 collagen e and is coexpressed with mRNA for the cartilage-specific proteoglycan, aggrecan . The removal of axon 2 during processing of pre-mRNA is correlated with a change in cell morphology from spindle shaped to rounded and the increased accumulation of extracellular matrix . This differential expression of the N11 2-propeptide in a tissuespecific manner raises the following intriguing questions . What is the function of the NH2-propeptide in ripe 11 and other interstitial collagens? Is there a role for type IIA procollagen in development? What are the factors that regulate the differential splicing of type H procollagen mRNA? Because of the relatively large alternatively spliced domain of type H procollagen (69 amino acids), its homology with other interstitial collagens, and the simplicity of the splicing pattern {axon 2 : in or out), this system provides an excellent model for study of the regulation of alternative splicing and role of the N112 -propeptide in interstitial collagens .
of Type HA and Type IM Procollagens Both type IIA and type IIB procollagens are synthesized and secreted by juvenile rastal chondrocyte cultures. Previously, we had shown that these cultures synthesized substantial amounts of both type HA and type IIB procollagen mMA (" and Sandell, 1WN The high level 4 synthesis 4 type IIA by these cells was somewhat surprising due to the predominant expression of type IIB in cartilage. However, these cells were derived from the pectus excavatum operation in which growing rib tips were removed, digested to free cells from the matrix, and cultured . In the cultures, the presence of type IIA could be accounted for by the cells undergoing chondrogenesis in the tissue or, on the other hand, in culture, these cells may be subject to less stringent controls permitting the synthesis type IIA procollagen mRNA . Evidence for the presence of both type RA and type IIB procollagen in costal cartilage is provided by in situ hybridization studies with fetal ribs where both probes for type IIA and type IIB hybridized to the tissue (Sandell, L. J., and J . Sugai, unpublished observations) .
From these studies, we do not know whether the type IIA and type IIB procollagens form homotrimers or heterotrimers. However, because type IIA and type IIB procollagens are synthesized primarily by different cell, and procollagen trimers are formed intracellularly, we assume that both type IIA and type IIB procollagens usually exist as homotrimers. A great deal of evidence indicates that the 0 chain of type XI collagen is a product of the COL2A1 gene, implying that a type II procollagen chain can be incorporated into more than one type of collagen molecule (Burgeson and Hollister, 1979) . When both type XI and type II collagen were isolated from the same cartilage tissue and separated on SDS-PAGE, the intact «3 chain appeared to be -10,000 D larger than the intact type II collagen chain (Wu, J., and D. Eyre, University of Washington, personal communication) . This 0 chain in bovine fetal cartilage is now known to be 1316 identical to the type IIB procollagen shown in this study : the 0 chain is larger than the a chain derived from type II collagen because the 0 chain is not cleaved by the processing proteinase that removes the NH2-propeptide from the type 11 molecule and, therefore, the amino acid sequence begins at the site of signal peptide cleavage . At this time, we do not know whether the chondroblasts or other type IIA collagencontaining tissues also express type XI collagen and consequently, we do not know whether type IIA collagen can also be incorporated into the type XI molecule.
Function of the NHZ-Propeptide
We have established the fact that two type II procollagen chains, differing in the presence or absence of the cysteinerich domain of the N112-propeptide can be transcribed, translated, and secreted in chondrocyte cultures . As shown in Fig. 1 , the N112-propeptide is characterized by a short globular domain followed by the interchain disulfide region, then a Gly-XY domain . In the type I collagen molecule, there are three chains : two cd(I) and one a2(I). The al(I) chain contains the cysteine-rich domain while the a2(I) chain, due to a truncated exon in the COL1A2 gene, does not contain the cysteine-rich domain (see Sandell and Boyd, 1990 , for a detailed comparison) . Consequently, in overall structure of the procollagen, the type HA chain resembles the al(I) polypeptide and the type IIB chain resembles the a2(I) polypeptide . Cleavage of the NHZ-and 000H-terminal extension peptides generally occurs extracellularly by specific neutral proteases presumably prior to collagen fibrillogenesis . In collagens type I and II, the removal of the propeptides is concomitant with fibrillogenesis . In types III (Fleischmajer et al., 1981) and V collagen (Fessler et al., 1981) , there is evidence for retention of the NHZ-propeptide in the mature collagen molecule. The propeptide may function after cleavage from the procollagen as the trimeric type I NHZ-propeptide has been isolated from bovine bone (Fisher et al., 1983) and is present in serum indicating that the NHZ-propeptide may have a role independent of its function in the intact procollagen . Two major functions have been suggested for the NHZpropeptide: (a) it plays a role in fibrillogenesis and (b) it plays a role in feedback inhibition of collagen synthesis . For example, Fleischmajer et al . (1985) reported that the diameter of collagen type I fibers was decreased from 35-40 to 20-30 nm by the presence of pN procollagen and that polymerization of the thin fibrils involved polymerization of pN collagen . The effect is thought to be physiologically relevant as they found significant amounts of pN collagen in chicken embryonic skin and showed that the ratio of pN procollagen to processed collagen varies with age, presumably due to different levels of N-proteinase activity. The role of the N112-propeptide in feedback regulation of collagen synthesis has been suggested by studies on dermatosporactic sheep and the human disease Ehlers-Danlos Syndrome Type IV In both of these diseases, the NHZ-propeptide is retained in the mature collagen molecule and increased synthesis of both type I and type III collagens was observed . When isolated N14 2-propeptides of type I and type III collagen were added directly to cultured fibroblasts, collagen synthesis was inhibited (Weistner et al., 1979) . Other in vitro studies support a function for the propeptides in regulation Sandell et al . Alternatively Spliced Procollagens of biosynthesis that may be mediated by a cell surface receptor (Weistner et al., 1979 ; Paglia et al ., 1981; Horlein et al., 1981; Wu et al., 1986 Wu et al., , 1991 Fleischmajer et al ., 1990) . In addition, there may be as yet uncharacterized interactions of the collagen NHZ-propeptide with other extracellular matrix molecules .
Chondrogenesis
The vertebral column is derived from mesenchymal cells that arise from the sclerotomes of the somites . Each sclerotome consists oftwo regions : loosely arranged cells cranially and densely packed cells caudally. It is commonly thought that the annulus fibrosis of the intervertebral disc is derived from the densely packed cells which move cranially to align with the center of the myotome (Moore, 1988) . The mesenchymal cells of the centrum are derived from the remaining densely packed cells, which fuse with the loosely arranged cells of the caudal sclerotome. Consequently, the centrum develops from two adjacent sclerotomes . Chondrification begins in two lateral centers of the centrum during the sixth week of embryogenesis and continues until the centers fuse to form the cartilagenous centrum . The chondrocytes in the center of the centrum/vertebral body begin to hypertrophy and ossification begins soon thereafter. The cells surrounding the centrum/vertebral body that express exon 2 are considered to serve as chondrogenic zones for the centra (O'Rahilly and Gardner, 1978) . Consequently, the splicing out of exon 2 may mark a new stage in chondrogenesis . This event could be responsible for determining whether type II mRNA containing cells proceed to chondrogenesis or proceed along another developmental pathway. The factor(s) necessary to remove exon 2 may be part of the chondrogenic phenotype and the control ofthis switch may be causal in chondrogenesis . On the other hand, the factors necessary for control may be present in the prechondrocytes directing inclusion ofexon 2 . The mesenchymal and fibroblast-like cells previously found to contain type II collagen mRNA (Hayashi et al., 1986) likely express the type IIA procollagen form that contains the N112-propeptide, while the chondrocytic cells express the alternatively spliced type IIB form. These cells, called the zone of progenitor cells in mouse neonatal condyles, incorporate [3H]thymidine at a higher rate than surrounding cell populations (Shurtz-Swinski et al., 1989) . The distinct cellular localization of the two different type II procollagens indicates that they may play different functional roles in distinct tissues . The expression of the NHZpropeptide is correlated with a low level of extracellular matrix deposition, while removal of exon 2 is correlated with increased synthesis and accumulation of the characteristically abundant cartilage matrix . The expression of type IIA procollagen mRNA present in the cartilage surrounding the vertebral body persists at least up to 122 d ofgestation (Sandell, L. J., and J. Sugai, unpublished observations) . This localization of type IIA procollagen during chondrogenesis is remarkably similar to the expression of the 6.4-kb form of cytotactin mRNA, also an alternatively spliced species (Prieto et al., 1990) , in embryonic chicken vertebral column .
Type IIA procollagen is also particularly abundant in the regions destined to form the articular cartilage ofjoint tissue both in the cartilage surrounding the vertebral bodies (Fig. 1317 4) and in the cartilage joining the dorsal vertebral processes (Fig. 8) . Type IIA procollagen distribution compared to type IIB procollagen distribution indicates that type IIA may be particularly localized in interface regions. Although a highly speculative suggestion, it is possible that type IIA procollagen expressed by these noncartilagenous cells functions to identify the region of joint formation .
These results have important implications for the regulation ofthe chondrocyte phenotype . It has previously been assumed that the phenotype was established by regulation at the level of transcription . Evidence showing increased accumulation of type II collagen mRNA and core protein as chondrogenesis proceeded in vitro (Vuorio et al ., 1982) supported the theory that as mesenchymal cells differentiated into chondrocytes, both type II collagen and proteoglycan gene expression increased coordinately. Upon closer examination, however, it was found quite consistently that the expression of type II mRNA preceded overt chondrogenesis (Kravis and Upholt, 1985; Kosher et al., 1986) and that some nonchondrocytic cells surrounding chondrogenic tissue contained type II procollagen mRNA (Hayashi et al., 1986) . We would predict that the expression of type II collagen in fibroblastic cells (Hayashi et al., 1986) as well as the prechondrogenic expression of mRNA established by Kosher et al ., (1986) and Kravis and Upholt (1985) is due to the expression of type IIA . Therefore, the expression of aggrecan may be coordinated with a change in the mRNA splice pattern of type II collagen in addition to an increase in transcription. It will be necessary to define the isoform of type II collagen synthesized in a variety of developmental and repair systems as all previous studies on type II collagen mRNA and type II collagen, in which the collagen was identified by cyanogen bromide mapping or type II-specific antibodies, would not have detected a difference between type IIA and type IIB procollagens .
Alternative splicing of pre-mRNA appears to play a role in development . Expression of alternatively spliced forms of fibronectin are correlated with development (ffrenchConstant and Hynes, 1988) and wound healing (ffrenchConstant et al., 1989) , however, the function of these alternatively spliced forms and their existence as fibronectin molecules have not been determined. In chondrocytes, two examples of alternative exon usage have been described that are relevant to the cartilage phenotype. First, type IX collagen, originally thought to be cartilage specific, is expressed in developing cornea, although a different promoter is used and a specific protein domain is removed (Nishimura et al., 1989; Muragaki et al ., 1990) . Secondly, Adams and colleagues (Bennett et al., 1989 ; Bennett and Adams, 1990) have shown that the COMA2 gene is expressed in chondrocytes, but again, a different promoter is employed yielding a protein product that is not collagenous . It has been suggested thatboth the alternative COLlA2 product (Bennettand Adams et al ., 1990 ) and the type I collagen NH2-propeptide (Wu et al., 1986 ) may function to inhibit collagen synthesis at a pretranslational level . Taken together, a pattern of events is beginning to emerge which determines the cartilage phenotype . These events are likely controlled by regulatory elements in the nucleus either acting on the DNA directly or on processing of pre-mRNA . Investigation of these nuclear events will broaden our understanding of chondrogenesis, cartilage repair processes, and skeletal dysplasias. The importance of a change in type II procollagen form is revealed by the expression of type HA procollagen in nonchondrocytic tissues and expression of type IIB procollagen in chondrocytes . A cell may not have the ability to exclude exon 2 by alternative splicing either due to the lack of a specific splicing factor or repression of alternative splicing and, as a consequence, proceed along with a completely different developmental route. Indeed, von tier Mark and colleagues (von tier Mark et al., 1976) have shown that type II collagen accumulates in the cell-free region adjacent to the embryonic notochord into which somitic sclerotomal cells expand prior to differentiating into vertebral cartilage . We have observed type HA procollagen mRNA, in situ, in the notochordal remnants of the developing intervertebral disk nucleus pulposus. The expression of type II procollagen in noncartilagenous portions of the embryo and spinal ganglion was surprising. However, in early embryogenesis, the notochord induces the overlying ectoderm to form the neural plate. The neural ectoderm differentiates into the central nervous system and spinal cord and cells from the neural ectoderm migrate to formthe spinal ganglia, the medulla ofthe adrenal gland, pigment cells, and other connective tissues of the head and neck. Possibly, in contrast to mature tissues, type II procollagen plays a different, more ubiquitous role during development . Indeed, Thorogood et al. (1986) , have found type II collagen at the epitheliomesenchymal interface and suggested that type II collagen may be instructive in future differentiation of the cartilagenous neurocranium . Finally, the recent findings of Kosher and Solursh (1989) showing immunoreactive type II collagen in a variety of embryonic basement membranes may be related to the expression of type IIA at the interfaces of developing vertebral column . Taken together, these results suggest the possibility thattype II collagen expression in these areas is actually type HA procollagen and chondrogenesis is dependent on the removal of exon 2 to synthesize type IIB procollagen . These results indicate that type II procollagen may play a more widespread role than previously suspected, particularly in developing tissues .
